INTERMEDIATE DOSE ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ADULT AML

被引：0
|
作者：
JEHN, U [1 ]
KOLB, HJ [1 ]
WILMANNS, W [1 ]
机构：
[1] UNIV MUNICH, MED KLIN 3, D-8000 MUNICH 70, FED REP GER
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [41] STANDARD INDUCTION AND LOW-DOSE ARA-C TREATMENT IN PATIENTS OVER 60 WITH AML OR MDS
    VANGEEL, BM
    HUIJGENS, PC
    OSSENKOPPELE, GJ
    WIJERMANS, PW
    LANGENHUIJSEN, MMAC
    NETHERLANDS JOURNAL OF MEDICINE, 1989, 35 (3-4): : 128 - 136
  • [42] Ara-C fever and infections after high-dose Ara-C treatment in pediatric lymphoid malignancies
    Ek, T
    Pinkava, M
    Abrahamsson, J
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (07) : 364 - 369
  • [43] Low Dose Ara-C Versus Low Dose Ara-C and Arsenic Trioxide: the UK NCRI AML16 "Pick a Winner" Comparison.
    Russell, Nigel H.
    Hills, Robert K.
    Hunter, Ann E.
    Milligan, Donald
    Kell, William J.
    Wheatley, Keith
    McMullin, Mary Frances
    Yin, John A. L.
    Bowen, David T.
    Burnett, A.
    BLOOD, 2009, 114 (22) : 201 - 201
  • [44] LOW-DOSE ARA-C AS AN ALTERNATIVE THERAPY FOR OLDER PATIENTS WITH AML
    HEYLL, A
    AUL, C
    HEYLL, U
    FISCHER, JT
    SCHNEIDER, W
    BLUT, 1985, 51 (03): : 163 - 163
  • [45] TREATMENT OF ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) UNRESPONSIVE TO OR RELAPSING FOLLOWING ARA-C THERAPY
    RAAB, SO
    SHAW, MT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 49 - 49
  • [46] NON-CARDIOGENIC PULMONARY-EDEMA COMPLICATING INTERMEDIATE AND HIGH-DOSE ARA-C TREATMENT FOR RELAPSED ACUTE-LEUKEMIA
    JEHN, U
    GOLDEL, N
    RIENMULLER, R
    WILMANNS, W
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (01): : 41 - 47
  • [47] RESULTS OF INDUCTION AND CONSOLIDATION TREATMENT WITH INTERMEDIATE AND HIGH-DOSE ARA-C AND META-AMSA CONTAINING REGIMENS IN PATIENTS WITH PRIMARILY FAILED OR RELAPSED ACUTE-LEUKEMIA AND NON-HODGKINS-LYMPHOMA
    PETERS, WG
    WILLEMZE, R
    COLLY, LP
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 36 : 7 - 16
  • [48] CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML) REFRACTORY TO ANTHRACYCLINE CYTARABINE (ARA-C) THERAPIES
    KALWINSKY, D
    LOOK, AT
    MIRRO, J
    DAHL, GV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 193 - 193
  • [49] High-dose liposomal daunorubicin (DNX) and Ara-C (HDAC) for refractory or relapsed acute leukemias: A dose searching study.
    Cortes, J
    Kantarjian, H
    O'Brien, S
    Giles, FJ
    Koller, C
    Beran, M
    Keating, M
    Estey, E
    BLOOD, 1998, 92 (10) : 234A - 234A
  • [50] Fludarabine, Cytarabine (ARA-C) and Pegylated Erwinase (PEGCRISANTASPASE) in Patients with Relapsed or Refractory Leukemia
    Almanza, Emmanuel
    Bataller, Alex
    Garcia-Manero, Guillermo
    Maiti, Abhishek
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Short, Nicholas J.
    Jabbour, Elias
    Ravandi, Farhad
    Valero, Yesid Alvarado
    Kadia, Tapan M.
    BLOOD, 2023, 142
12345